Status:
COMPLETED
Lactate and Complications in Cytoreduction Surgery for Peritoneal Carcinomatosis
Lead Sponsor:
Hospital General Universitario de Castellón
Conditions:
Lactacidemia and Complications
Eligibility:
All Genders
Brief Summary
Serum lactate is a risk factor for postoperative complications in patients undergoing cytoreduction surgery in peritoneal carcinomatosis
Detailed Description
Background. Cytoreduction surgery has been developed as a treatment of peritoneal carcinomatosis. However, this surgery is associated with important complications. The present study attempts to assess...
Eligibility Criteria
Inclusion
- patients diagnosed with peritoneal carcinomatosis who underwent cytoreduction surgery in the Multidisciplinary Unit of Abdomino-Pelvic Oncology Surgery (MUAPOS) of the University General Hospital of Castellón.
Exclusion
- patients without lactic acid levels in the register.
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT04307654
Start Date
January 1 2014
End Date
January 1 2016
Last Update
March 13 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.